Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-17

Clinical Trial Update: Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tapentadol with oxycodone for peripheral neuropathic pain was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)
  • Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Peripheral Neuropathy | Phase 4 | Status: TERMINATED | Results posted: 2024-12-17